CN Patent

CN106220639A — 一种维帕他韦中间体新晶型

Assigned to SHANGHAI FOREFRONT PHARMA · Expires 2016-12-14 · 9y expired

What this patent protects

本发明涉及一种维帕他韦中间体新晶型。具体地，本发明公开了式I化合物的多晶型物及其制备方法，所述多晶型物具有良好的纯化效果。

USPTO Abstract

本发明涉及一种维帕他韦中间体新晶型。具体地，本发明公开了式I化合物的多晶型物及其制备方法，所述多晶型物具有良好的纯化效果。

Drugs covered by this patent

Patent Metadata

Patent number: CN106220639A
Jurisdiction: CN
Classification: —
Expires: 2016-12-14
Drug substance claim: No
Drug product claim: No
Assignee: SHANGHAI FOREFRONT PHARMA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.